Cargando…
Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?()
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI).
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437477/ https://www.ncbi.nlm.nih.gov/pubmed/32703528 http://dx.doi.org/10.1016/j.rceng.2020.06.004 |
| _version_ | 1783572632511184896 |
|---|---|
| author | López Reboiro, M.L. Sardiña González, C. López Castro, J. |
| author_facet | López Reboiro, M.L. Sardiña González, C. López Castro, J. |
| author_sort | López Reboiro, M.L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7437477 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74374772020-08-20 Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?() López Reboiro, M.L. Sardiña González, C. López Castro, J. Rev Clin Esp (Barc) Correspondence Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). 2020-10 2020-08-19 /pmc/articles/PMC7437477/ /pubmed/32703528 http://dx.doi.org/10.1016/j.rceng.2020.06.004 Text en © 2020 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence López Reboiro, M.L. Sardiña González, C. López Castro, J. Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?() |
| title | Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?() |
| title_full | Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?() |
| title_fullStr | Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?() |
| title_full_unstemmed | Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?() |
| title_short | Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?() |
| title_sort | reply to: ivermectin in covid-19. argumentum ad ignorantiam?() |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437477/ https://www.ncbi.nlm.nih.gov/pubmed/32703528 http://dx.doi.org/10.1016/j.rceng.2020.06.004 |
| work_keys_str_mv | AT lopezreboiroml replytoivermectinincovid19argumentumadignorantiam AT sardinagonzalezc replytoivermectinincovid19argumentumadignorantiam AT lopezcastroj replytoivermectinincovid19argumentumadignorantiam |